Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Targeted Sequencing and Resequencing Market to reach USD 20.91 billion by the end of 2029

Global Targeted Sequencing and Resequencing Market Size study & Forecast, by Technology (Sequencing, Resequencing) by Type (DNA, RNA), by Application (Clinical Application, Plant & animal sciences, Drug development, Others), by End-use (Hospitals & clinics, Academic Research, Others) and Regional Analysis, 2022-2029

Product Code: HLSB-99303321
Publish Date: 20-03-2023
Page: 200

Global Targeted Sequencing and Resequencing Market is valued at approximately USD 4.1 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 22.59% over the forecast period 2022-2029. Targeted Sequencing is a method of detecting unusual variants in a certain set of genes whereas, Resequencing is a method in which a subset of genes is isolated and sequenced. Targeted Sequencing and Resequencing are the methods used for the sequencing of a portion of a person’s genome to look for sequence discrepancies between that person and the species’ typical genome. Shotgun and high throughput are the two main types of DNA sequencing. Targeted sequencing and resequencing are used for the detection of mutations in DNA caused by various congenital diseases. In comparison to WGS and other survey methods, it provides a proper analysis of the results and prevents the erroneous interpretation of sequencing data. Cost-saving advantages of full genome sequencing, increasing R&D investments in the pharmaceutical industry, advantages of amplicon sequencing and targeted gene panels and Technological advancements in sequencing technology are the factors driving the major market growth.

According to the National Library of Medicine, full genome sequencing costs about $10 million in 2007. Since then, sequencing prices have decreased rapidly, and it is expected that the $1000 genome will soon become a reality. Additionally, in 2019, R&D expenditures in the pharmaceutical business were $83 billion. Particularly, between 2015 and 2019, investment in pharmaceutical R&D surged by about 50%. Increasing R&D investments leads to the development of innovative Sequencing and Resequencing techniques. Cost-saving advantages of full genome sequencing and increasing research and development investments in the pharmaceutical industry are the major factors driving the growth of the market. Other components driving market increase are the advantages of amplicon sequencing and targeted gene panels and Technological advancements in sequencing technology. Furthermore, emerging digital next-generation sequencing technology and advancements to perform sequencing in less time are the factors creating major market opportunities in the forecast period. However, the high cost of maintaining Targeted Sequencing and Resequencing stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Targeted Sequencing And Resequencing Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of market players, increasing advancements in technology, and the region’s increasing development of sequencing capabilities. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as increasing investments in research & development, the prevalence of advanced technology for drug development and discovery, and the geographic expansion of key players.
Major market player included in this report are:
Illumina, Inc.
F. Hoffmann-La Roche Ltd
Agilent Technologies Inc.
GATC Biotech Ag
Oxford Nanopore Technologies
Thermo Fisher Scientific, Inc.
DNASTAR Inc.
QIAGEN
BGI
Perkin Elmer, Inc.
Recent Developments in the Market:
 In January 2021, Illumina announced several collaborations between Merck, Myriad Genetics, Kura Oncology, and Bristol Myers Squibb that support the company’s goal of creating standardized, widely available tools for precision oncology.
 In Aug 2022, The Medical Device Innovation Consortium (MDIC) introduced Somatic Reference Samples (SRS), an initiative to improve NGS-based cancer diagnosis by validating and developing public genomic datasets and therapeutically relevant samples.
Global Targeted Sequencing And Resequencing Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Technology, Type, Application, End-use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Sequencing
Re-sequencing

By Type:
DNA
RNA

By Application:
Clinical Application
Plant & animal sciences
Drug development
Others

By End-use:
Hospitals & clinics
Academic Research
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Targeted Sequencing And Resequencing Market, by Region, 2019-2029 (USD Billion)
1.2.2. Targeted Sequencing And Resequencing Market, by Technology, 2019-2029 (USD Billion)
1.2.3. Targeted Sequencing And Resequencing Market, by Type, 2019-2029 (USD Billion)
1.2.4. Targeted Sequencing And Resequencing Market, by Application, 2019-2029 (USD Billion)
1.2.5. Targeted Sequencing And Resequencing Market, by End-use, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Targeted Sequencing and Resequencing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Targeted Sequencing and Resequencing Market Dynamics
3.1. Targeted Sequencing and Resequencing Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Decreasing cost of full genome sequencing
3.1.1.2. increasing R&D investments in the pharmaceutical industry
3.1.2. Market Challenges
3.1.2.1. High Cost of maintaining Targeted Sequencing and Resequencing technology
3.1.3. Market Opportunities
3.1.3.1. Emerging digital next-generation sequencing technology
3.1.3.2. Advancements to perform sequencing in less time.
Chapter 4. Global Targeted Sequencing and Resequencing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Targeted Sequencing And Resequencing Market, by Technology
6.1. Market Snapshot
6.2. Global Targeted Sequencing And Resequencing Market by Technology, Performance – Potential Analysis
6.3. Global Targeted Sequencing And Resequencing Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
6.4. Targeted Sequencing And Resequencing Market, Sub Segment Analysis
6.4.1. Sequencing
6.4.2. Re-sequencing
Chapter 7. Global Targeted Sequencing And Resequencing Market, by Type
7.1. Market Snapshot
7.2. Global Targeted Sequencing And Resequencing Market by Type, Performance – Potential Analysis
7.3. Global Targeted Sequencing And Resequencing Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
7.4. Targeted Sequencing And Resequencing Market, Sub Segment Analysis
7.4.1. DNA
7.4.2. RNA
Chapter 8. Global Targeted Sequencing And Resequencing Market, by Application
8.1. Market Snapshot
8.2. Global Targeted Sequencing And Resequencing Market by Application, Performance – Potential Analysis
8.3. Global Targeted Sequencing And Resequencing Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
8.4. Targeted Sequencing And Resequencing Market, Sub Segment Analysis
8.4.1. Clinical Application
8.4.2. Plant & animal sciences
8.4.3. Drug development
8.4.4. Oyhers
Chapter 9. Global Targeted Sequencing And Resequencing Market, by End-use
9.1. Market Snapshot
9.2. Global Targeted Sequencing And Resequencing Market by End-use, Performance – Potential Analysis
9.3. Global Targeted Sequencing And Resequencing Market Estimates & Forecasts by End-use 2019-2029 (USD Billion)
9.4. Targeted Sequencing And Resequencing Market, Sub Segment Analysis
9.4.1. Hospitals & Clinics
9.4.2. Academic ResearchOthers
Chapter 10. Global Targeted Sequencing And Resequencing Market, Regional Analysis
10.1. Targeted Sequencing And Resequencing Market, Regional Market Snapshot
10.2. North America Targeted Sequencing And Resequencing Market
10.2.1. U.S. Targeted Sequencing And Resequencing Market
10.2.1.1. Technology breakdown estimates & forecasts, 2019-2029
10.2.1.2. Type breakdown estimates & forecasts, 2019-2029
10.2.1.3. Application breakdown estimates & forecasts, 2019-2029
10.2.1.4. End-use breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Targeted Sequencing And Resequencing Market
10.3. Europe Targeted Sequencing And Resequencing Market Snapshot
10.3.1. U.K. Targeted Sequencing And Resequencing Market
10.3.2. Germany Targeted Sequencing And Resequencing Market
10.3.3. France Targeted Sequencing And Resequencing Market
10.3.4. Spain Targeted Sequencing And Resequencing Market
10.3.5. Italy Targeted Sequencing And Resequencing Market
10.3.6. Rest of Europe Targeted Sequencing And Resequencing Market
10.4. Asia-Pacific Targeted Sequencing And Resequencing Market Snapshot
10.4.1. China Targeted Sequencing And Resequencing Market
10.4.2. India Targeted Sequencing And Resequencing Market
10.4.3. Japan Targeted Sequencing And Resequencing Market
10.4.4. Australia Targeted Sequencing And Resequencing Market
10.4.5. South Korea Targeted Sequencing And Resequencing Market
10.4.6. Rest of Asia Pacific Targeted Sequencing And Resequencing Market
10.5. Latin America Targeted Sequencing And Resequencing Market Snapshot
10.5.1. Brazil Targeted Sequencing And Resequencing Market
10.5.2. Mexico Targeted Sequencing And Resequencing Market
10.6. Rest of The World Targeted Sequencing And Resequencing Market

Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Illumina, Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. F. Hoffmann-La Roche Ltd
11.2.3. Agilent Technologies Inc.
11.2.4. GATC Biotech Ag
11.2.5. Oxford Nanopore Technologies
11.2.6. Thermo Fisher Scientific, Inc.
11.2.7. DNASTAR Inc.
11.2.8. QIAGEN
11.2.9. BGI
11.2.10. Perkin Elmer, Inc.
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now